Bibliography
- Narumiya S, Sugimoto Y, Ushikubi F. Prostanoid receptors: structures, properties, and functions. Physiol Rev 1999;79(4):1193-226
- Wilson RJ, Rhodes SA, Wood RL, et al. Functional pharmacology of human prostanoid EP2 and EP4 receptors. Eur J Pharmacol 2004;501(1-3):49-58
- Namkoong S, Lee SJ, Kim CK, et al. Prostaglandin E2 stimulates angiogenesis by activating the nitric oxide/cGMP pathway in human umbilical vein endothelial cells. Exp Mol Med 2005;37(6):588-600
- Axelrad TW, Kakar S, Einhorn TA. New technologies for the enhancement of skeletal repair. Injury 2007;38(Suppl 1):S49-62
- Singh GK, Fong LV, Salmon AP, Keeton BR. Study of low dosage prostaglandin: usages and complications. Eur Heart J 1994;15(3):377-81
- Cattral MS, Altraif I, Greig PD, et al. Toxic effects of intravenous and oral prostaglandin E therapy in patients with liver disease. Am J Med 1994;97(4):369-73
- Khan MH, Li Z, Wang JH. Repeated exposure of tendon to prostaglandin-E2 leads to localized tendon degeneration. Clin J Sport Med 2005;15(1):27-33
- Voegeli TL, Chapman MW. Utilization of prostaglandin in fracture healing [abstract]. Trans Orthop Res Soc 1985;10:134
- Doggrell SA. Misoprostol for the treatment of early pregnancy failure. Curr Clin Pharmacol 2007;2(1):1-9
- Stadler TC, Becker AJ, Stief CG. [Modern treatment of erectile dysfunction]. MMW Fortschr Med 2008;150(15):41-3
- Hartke JR, Lundy MW. Bone anabolic therapy with selective prostaglandin analogs. J Musculoskelet Neuronal Interact 2001;2(1):25-31
- Kawaguchi H, Pilbeam CC, Harrison JR, Raisz LG. The role of prostaglandins in the regulation of bone metabolism. Clin Orthop Relat Res 1995;(313):36-46
- Li M, Thompson DD, Paralkar VM. Prostaglandin E(2) receptors in bone formation. Int Orthop 2007;31(6):767-72
- Ke HZ, Shen VW, Qi H, et al. Prostaglandin E2 increases bone strength in intact rats and in ovariectomized rats with established osteopenia. Bone 1998;23(3):249-55
- Li XJ, Jee WS, Li YL, Patterson-buckendahl P. Transient effects of subcutaneously administered prostaglandin E2 on cancellous and cortical bone in young adult dogs. Bone 1990;11(5):353-64
- Dekel S, Lenthall G, Francis MJ. Release of prostaglandins from bone and muscle after tibial fracture. An experimental study in rabbits. J Bone Joint Surg Br 1981;63-B(2):185-9
- Keller J, Bunger C, Andreassen TT, et al. Bone repair inhibited by indomethacin. Effects on bone metabolism and strength of rabbit osteotomies. Acta Orthop Scand 1987;58(4):379-83
- Suzawa T, Miyaura C, Inada M, et al. The role of prostaglandin E receptor subtypes (EP1, EP2, EP3, and EP4) in bone resorption: an analysis using specific agonists for the respective EPs. Endocrinology 2000;141(4):1554-9
- Breyer RM, Bagdassarian CK, Myers SA, Breyer MD. Prostanoid receptors: subtypes and signaling. Annu Rev Pharmacol Toxicol 2001;41:661-90
- Hakeda Y, Yoshino T, Natakani Y, et al. Prostaglandin E2 stimulates DNA synthesis by a cyclic AMP-independent pathway in osteoblastic clone MC3T3-E1 cells. J Cell Physiol 1986;128(2):155-61
- Chase LR, Aurbach GD. The effect of parathyroid hormone on the concentration of adenosine 3′,5′-monophosphate in skeletal tissue in vitro. J Biol Chem 1970;245(7):1520-6
- Yu JH, Wells H, Ryan WJ, Lloyd WS. Effects of prostaglandins and other drugs on the cyclic AMP content of cultured bone cells. Prostaglandins 1976;12(4):501-13
- Marcus R, Orner FB. Cyclic AMP production in rat calvaria in vitro: interaction prostaglandins with parathyroid hormone. Endocrinology 1977;101(5):1570-8
- Alander CB, Raisz LG. Effects of selective prostaglandins E2 receptor agonists on cultured calvarial murine osteoblastic cells. Prostaglandins Other Lipid Mediat 2006;81(3-4):178-83
- Suda M, Tanaka K, Natsui K, et al. Prostaglandin E receptor subtypes in mouse osteoblastic cell line. Endocrinology 1996;137(5):1698-705
- Weinreb M, Machwate M, Shir N, et al. Expression of the prostaglandin E(2) (PGE(2)) receptor subtype EP(4) and its regulation by PGE(2) in osteoblastic cell lines and adult rat bone tissue. Bone 2001;28(3):275-81
- Weinreb M, Grosskopf A, Shir N. The anabolic effect of PGE2 in rat bone marrow cultures is mediated via the EP4 receptor subtype. Am J Physiol 1999;276(2 Pt 1):E376-83
- Sarrazin P, Bkaily G, Hache R, et al. Characterization of the prostaglandin receptors in human osteoblasts in culture. Prostaglandins Leukot Essent Fatty Acids 2001;64(3):203-10
- Billot X, Chateauneuf A, Chauret N, et al. Discovery of a potent and selective agonist of the prostaglandin EP4 receptor. Bioorg Med Chem Lett 2003;13(6):1129-32
- Maruyama T, Asada M, Shiraishi T, et al. Design and synthesis of a selective EP4-receptor agonist. Part 3: 16-phenyl-5-thiaPGE(1) and 9-beta-halo derivatives with improved stability. Bioorg Med Chem 2002;10(6):1743-59
- Shamir D, Keila S, Weinreb M. A selective EP4 receptor antagonist abrogates the stimulation of osteoblast recruitment from bone marrow stromal cells by prostaglandin E2 in vivo and in vitro. Bone 2004;34(1):157-62
- Sakuma Y, Li Z, Pilbeam CC, et al. Stimulation of cAMP production and cyclooxygenase-2 by prostaglandin E(2) and selective prostaglandin receptor agonists in murine osteoblastic cells. Bone 2004;34(5):827-34
- Faour WH, He Y, He QW, et al. Prostaglandin E(2) regulates the level and stability of cyclooxygenase-2 mRNA through activation of p38 mitogen-activated protein kinase in interleukin-1 beta-treated human synovial fibroblasts. J Biol Chem 2001;276(34):31720-31
- Hinz B, Brune K, Pahl A. Cyclooxygenase-2 expression in lipopolysaccharide-stimulated human monocytes is modulated by cyclic AMP, prostaglandin E(2), and nonsteroidal anti-inflammatory drugs. Biochem Biophys Res Commun 2000;278(3):790-6
- Mano M, Arakawa T, Mano H, et al. Prostaglandin E2 directly inhibits bone-resorbing activity of isolated mature osteoclasts mainly through the EP4 receptor. Calcif Tissue Int 2000;67(1):85-92
- Okada Y, Lorenzo JA, Freeman AM, et al. Prostaglandin G/H synthase-2 is required for maximal formation of osteoclast-like cells in culture. J Clin Invest 2000;105(6):823-32
- Kaji H, Sugimoto T, Kanatani M, et al. Prostaglandin E2 stimulates osteoclast-like cell formation and bone-resorbing activity via osteoblasts: role of cAMP-dependent protein kinase. J Bone Miner Res 1996;11(1):62-71
- Zhan P, Alander C, Kaneko H, et al. Effect of deletion of the prostaglandin EP4 receptor on stimulation of calcium release from cultured mouse calvariae: impaired responsiveness in heterozygotes. Prostaglandins Other Lipid Mediat 2005;78(1-4):19-26
- Raisz LG, Woodiel FN. Effects of selective prostaglandin EP2 and EP4 receptor agonists on bone resorption and formation in fetal rat organ cultures. Prostaglandins Other Lipid Mediat 2003;71(3-4):287-92
- Ono K, Akatsu T, Murakami T, et al. Important role of EP4, a subtype of prostaglandin (PG) E receptor, in osteoclast-like cell formation from mouse bone marrow cells induced by PGE2. J Endocrinol 1998;158(3):R1-5
- Sakuma Y, Tanaka K, Suda M, et al. Crucial involvement of the EP4 subtype of prostaglandin E receptor in osteoclast formation by proinflammatory cytokines and lipopolysaccharide. J Bone Miner Res 2000;15(2):218-27
- Li X, Okada Y, Pilbeam CC, et al. Knockout of the murine prostaglandin EP2 receptor impairs osteoclastogenesis in vitro. Endocrinology 2000;141(6):2054-61
- Yoshida K, Oida H, Kobayashi T, et al. Stimulation of bone formation and prevention of bone loss by prostaglandin E EP4 receptor activation. Proc Natl Acad Sci U S A 2002;99(7):4580-5
- Ke HZ, Crawford DT, Qi H, et al. A nonprostanoid EP4 receptor selective prostaglandin E2 agonist restores bone mass and strength in aged, ovariectomized rats. J Bone Miner Res 2006;21(4):565-75
- Machwate M, Harada S, Leu CT, et al. Prostaglandin receptor EP(4) mediates the bone anabolic effects of PGE(2). Mol Pharmacol 2001;60(1):36-41
- Hagino H, Kuraoka M, Kameyama Y, et al. Effect of a selective agonist for prostaglandin E receptor subtype EP4 (ONO-4819) on the cortical bone response to mechanical loading. Bone 2005;36(3):444-53
- Turner CH, Akhter MP, Raab DM, et al. A noninvasive, in vivo model for studying strain adaptive bone modeling. Bone 1991;12(2):73-9
- Torrance AG, Mosley JR, Suswillo RF, Lanyon LE. Noninvasive loading of the rat ulna in vivo induces a strain-related modeling response uncomplicated by trauma or periostal pressure. Calcified Tissue Int 1994;54(3):241-7
- Onishi E, Fujibayashi S, Takemoto M, et al. Enhancement of bone-bonding ability of bioactive titanium by prostaglandin E2 receptor selective agonist. Biomaterials 2008;29(7):877-83
- Marui A, Hirose K, Maruyama T, et al. Prostaglandin E2 EP4 receptor-selective agonist facilitates sternal healing after harvesting bilateral internal thoracic arteries in diabetic rats. J Thorac Cardiovasc Surg 2006;131(3):587-93
- Tanaka M, Sakai A, Uchida S, et al. Prostaglandin E2 receptor (EP4) selective agonist (ONO-4819.CD) accelerates bone repair of femoral cortex after drill-hole injury associated with local upregulation of bone turnover in mature rats. Bone 2004;34(6):940-8
- Zhang X, Schwarz EM, Young DA, et al. Cyclooxygenase-2 regulates mesenchymal cell differentiation into the osteoblast lineage and is critically involved in bone repair. J Clin Invest 2002;109(11):1405-15
- Naik AA, Xie C, Zuscik MJ, et al. Reduced COX-2 Expression in Aged Mice Is Associated With Impaired Fracture Healing. J Bone Miner Res 2009;24(2):251-64
- Li M, Ke HZ, Qi H, et al. A novel, non-prostanoid EP2 receptor-selective prostaglandin E2 agonist stimulates local bone formation and enhances fracture healing. J Bone Miner Res 2003;18(11):2033-42
- Choudhary S, Alander C, Zhan P, et al. Effect of deletion of the prostaglandin EP2 receptor on the anabolic response to prostaglandin E2 and a selective EP2 receptor agonist. Prostaglandins Other Lipid Mediat 2008;86(1-4):35-40
- Ono K, Kaneko H, Choudhary S, et al. Biphasic effect of prostaglandin E2 on osteoclast formation in spleen cell cultures: role of the EP2 receptor. J Bone Miner Res 2005;20(1):23-9
- Akhter MP, Cullen DM, Gong G, Recker RR. Bone biomechanical properties in prostaglandin EP1 and EP2 knockout mice. Bone 2001;29(2):121-5
- Suda T, Udagawa N, Nakamura I, et al. Modulation of osteoclast differentiation by local factors. Bone 1995;17(2 Suppl):87S-91S
- Quinn JM, Elliott J, Gillespie MT, Martin TJ. A combination of osteoclast differentiation factor and macrophage-colony stimulating factor is sufficient for both human and mouse osteoclast formation in vitro. Endocrinology 1998;139(10):4424-7
- Li X, Pilbeam CC, Pan L, et al. Effects of prostaglandin E2 on gene expression in primary osteoblastic cells from prostaglandin receptor knockout mice. Bone 2002;30(4):567-73
- Paralkar VM, Borovecki F, Ke HZ, et al. An EP2 receptor-selective prostaglandin E2 agonist induces bone healing. Proc Natl Acad Sci USA 2003;100(11):6736-40
- Nemoto K, Pilbeam CC, Bilak SR, Raisz LG. Molecular cloning and expression of a rat prostaglandin E2 receptor of the EP2 subtype. Prostaglandins 1997;54(4):713-25
- Kasugai S, Oida S, Iimura T, et al. Expression of prostaglandin E receptor subtypes in bone: expression of EP2 in bone development. Bone 1995;17(1):1-4
- Boie Y, Stocco R, Sawyer N, et al. Molecular cloning and characterization of the four rat prostaglandin E2 prostanoid receptor subtypes. Eur J Pharmacol 1997;340(2-3):227-41
- Nakagawa K, Imai Y, Ohta Y, Takaoka K. Prostaglandin E2 EP4 agonist (ONO-4819) accelerates BMP-induced osteoblastic differentiation. Bone 2007;41(4):543-8